INS and Hyperglycemia: Recommended glucose targets in non-critical care are not attainable by many health-care institutions with conventional insulin therapy.13, 14 In this study, the benefits of fully closed-loop glycaemic control suggest that this technology has the potential to substantially improve management of hyperglycaemia in one of the most challenging inpatient populations.